CARNITOR SF (levocarnitine) by Leadiant Biosciences is clinical pharmacology carnitor (levocarnitine) is a naturally occurring substance required in mammalian energy metabolism. First approved in 1986.
Drug data last refreshed 17h ago · AI intelligence enriched 3d ago
CARNITOR SF (levocarnitine) is an oral solution containing a naturally occurring substance essential for cellular energy metabolism. It facilitates long-chain fatty acid entry into mitochondria for oxidation and ATP production, and is used to treat primary and secondary carnitine deficiency, including inborn errors of metabolism such as glutaric aciduria II, methylmalonic aciduria, and propionic acidemia. The drug works by clearing toxic acylCoA compounds through formation of acylcarnitine, which is rapidly excreted.
Minimal commercial activity with only $7K in Part D spending and 34 claims suggests a niche, stable product with limited team expansion potential.
CLINICAL PHARMACOLOGY CARNITOR (levocarnitine) is a naturally occurring substance required in mammalian energy metabolism. It has been shown to facilitate long-chain fatty acid entry into cellular mitochondria, thereby delivering substrate for oxidation and subsequent energy production. Fatty acids…
Worked on CARNITOR SF at Leadiant Biosciences? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Carnitine Analog
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on CARNITOR SF offers stable but limited career growth, as the product is a niche, mature therapeutic with minimal job openings (zero linked positions) and declining commercial investment. This role suits professionals seeking deep expertise in rare metabolic diseases and orphan/specialty pharmacy rather than high-visibility career progression.